Biotech News
Arrowhead Pharmaceuticals Reports 2026 Fiscal Year-End Results
- Conference Call and Webcast Today, November 12, 2026, at 4:30 p.m. ET PASADENA, Calif. --(BUSINESS WIRE)--Nov. 12, 2026-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2026 fiscal year ended September 30, 2026.
